Funded startups/VOLITIONRX LTD
VL

VOLITIONRX LTD

SEC filing
Biotechnology · Henderson, NV
Form D on EDGAR
Amount raised$22.7Msold at filing
Total offering$22.7M
Investors in the raise1count reported to the SEC
FiledJan 28, 2026first sale May 20, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Alan Thomas ColmanDirector
Ethel I RubinDirector
Terig HughesExecutive Officer
Kim Archibald NguyenDirector
Salvatore Thomas ButeraExecutive Officer
Rodney RootsaertExecutive Officer
Louise BatchelorExecutive Officer
Gael Thomas ForterreExecutive Officer
Gaetan Thomas MichelExecutive Officer
Timothy I StillDirector
Phillip Archibald BarnesDirector
Jasmine Thomas KwayExecutive Officer

Executive officers, directors and promoters as listed on the Form D.

Filing history

FormFiledAmount soldOffering
D/AJan 28, 2026$22.7M$22.7MEDGAR
DMay 30, 2025$16.3M$16.3MEDGAR